Shmuel Zvi - SOL-GEL TECHN Independent Director

All Insiders . Germany . 
Stock . SOL GEL TECHN IS 10 . Stakeholders . Insider . Shmuel Zvi
4SG Stock  EUR 0.39  0.04  11.43%   

Insider

Shmuel Zvi is Independent Director of SOL GEL TECHN IS 10
Age 58
Phone972 8 931 3433
Webhttp://www.sol-gel.com

SOL-GEL TECHN Management Efficiency

The company has return on total asset (ROA) of 0.0471 % which means that it generated a profit of $0.0471 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1101 %, meaning that it generated $0.1101 on every $100 dollars invested by stockholders. SOL-GEL TECHN's management efficiency ratios could be used to measure how well SOL-GEL TECHN manages its routine affairs as well as how well it operates its assets and liabilities.
SOL GEL TECHN IS 10 has accumulated 1.61 M in total debt with debt to equity ratio (D/E) of 0.04, which may suggest the company is not taking enough advantage from borrowing. SOL GEL TECHN has a current ratio of 7.86, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist SOL-GEL TECHN until it has trouble settling it off, either with new capital or with free cash flow. So, SOL-GEL TECHN's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like SOL GEL TECHN sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for SOL-GEL to invest in growth at high rates of return. When we think about SOL-GEL TECHN's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Laichang ZouZijin Mining Group
55
Mike LiangAmkor Technology
N/A
Arve NilsenEidesvik Offshore ASA
N/A
Farshad HaghighiAmkor Technology
60
Lars EngelsenEidesvik Offshore ASA
N/A
Jennifer JueAmkor Technology
N/A
Giel RuttenAmkor Technology
66
Jinghe ChenZijin Mining Group
66
Megan FaustAmkor Technology
49
Erling LoddenEidesvik Offshore ASA
N/A
Cheung FanZijin Mining Group
63
Honghui WuZijin Mining Group
47
Susan KimAmkor Technology
60
James KimAmkor Technology
87
Jianhui WuZijin Mining Group
N/A
Xionghui XieZijin Mining Group
49
Gitte TalmoEidesvik Offshore ASA
N/A
Hongfu LinZijin Mining Group
49
Petter LonningEidesvik Offshore ASA
N/A
Steve ShinAmkor Technology
60
Hongying LinZijin Mining Group
55
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company was incorporated in 1997 and is headquartered in Ness Ziona, Israel. SOL GEL operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 65 people. SOL GEL TECHN IS 10 (4SG) is traded on Frankfurt Exchange in Germany and employs 53 people.

Management Performance

Return On Equity0.11
Return On Asset0.0471

SOL GEL TECHN Leadership Team

Elected by the shareholders, the SOL-GEL TECHN's board of directors comprises two types of representatives: SOL-GEL TECHN inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SOL-GEL. The board's role is to monitor SOL-GEL TECHN's management team and ensure that shareholders' interests are well served. SOL-GEL TECHN's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SOL-GEL TECHN's outside directors are responsible for providing unbiased perspectives on the board's policies.
Shmuel Zvi, Independent Director
Nissim Bilman, Vice President - Quality
Dubi Zamir, Vice President - Special Projects
Hani Lerman, Director
Itzik Yosef, Vice President - Operations
Yaffa KrindelSieradzki, Independent Director
Gilad Mamlok, Chief Financial Officer
Itai Arkin, Director
John Vieira, U.S. Head of Commercialization
Alon SeriLevy, Chief Executive Officer, Co-Founder, Director
Karine Neimann, Vice President - Projects and Planning, Chief Chemist
Ran Gottfried, Independent Director
Jonathan Siegel, Independent Director
Ofer Toledano, Vice President - Research & Development
Jerrold Gattegno, Independent Director
Moshe Arkin, Chairman of the Board
Ofra LevyHacham, Vice President - Clinical and Regulatory Affairs

SOL-GEL Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SOL-GEL TECHN a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.11
Return On Asset0.0471
Profit Margin0.20 %
Operating Margin0.16 %
Shares Outstanding23.13 M
Shares Owned By Insiders74.06 %
Shares Owned By Institutions13.95 %
Revenue24.59 M
Gross Profit10.89 M
EBITDA4.75 M

Currently Active Assets on Macroaxis

RSIRush Street Interactive
OKTAOkta Inc
BACBank of America
SSentinelOne
WDWalker Dunlop

Other Information on Investing in SOL-GEL Stock

SOL-GEL TECHN financial ratios help investors to determine whether SOL-GEL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SOL-GEL with respect to the benefits of owning SOL-GEL TECHN security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY